A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Summary

The purpose of this study is to evaluate the safety of AC-170 0.24% used twice daily in Healthy Adult Subjects and in Pediatric subjects with a history or family history of atopic disease (including allergic conjunctivitis).

Timeline

Start

2014-05

Primary completion

2014-10

Completion

2014-10

Drugs

Indications